| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000036686 |
| Receipt No. | R000041794 |
| Scientific Title | Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI |
| Date of disclosure of the study information | 2019/05/10 |
| Last modified on | 2022/05/31 (Ver. 6) |
| Basic information | ||
| Public title | Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI | |
| Acronym | Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI | |
| Scientific Title | Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI | |
| Scientific Title:Acronym | Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI | |
| Region |
|
|
| Condition | ||
| Condition | Chronic pancreatitis, Autoimmune pancreatitis,Sphincter of Oddi dysfunction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In patients with suspected biliary and pancreatic fluid outflow disorders (pathology), use cinedynamic MRI to investigate whether pancreatic fluid and biliary outflow disorders can be diagnosed. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Comparison of biliary and pancreatic fluid outflow in cinedynamic MRCP in healthy volunteer groups and disease groups suspected of biliary and pancreatic fluid outflow disorders. |
| Key secondary outcomes | Evaluation of outflow capacity according to disease. Diagnosis and evaluation after duodenal papillary sphincter dysfunction. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | One MRI examination is performed on a group of healthy volunteers. | |
| Interventions/Control_2 | Disease group is usually examined in the medical practice. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients suspected of bile or pancreatic fluid outflow disorder by other imaging tests.
Patients who obtained written consent by their own intention about participation in this study. |
|||
| Key exclusion criteria | Patients whose MRI images are difficult to evaluate due to artifacts.
Patients who could not carry out MRI examination for some reason. Patients who were judged inappropriate by the person in charge of this study. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kobe University | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 650-0017 | ||||||
| Address | 7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan | ||||||
| TEL | 078-382-6305 | ||||||
| atmasuda@med.kobe-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kobe University | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 650-0017 | ||||||
| Address | 7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan | ||||||
| TEL | 078-382-6305 | ||||||
| Homepage URL | |||||||
| sashina@med.kobe-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kobe University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kobe University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kobe University |
| Address | 7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan |
| Tel | 078-382-6669 |
| kainyu@med.kobe-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 32 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041794 |